Transgene Biotek P/E Ratio
Transgene Biotek (TRABI) P/E ratio is not applicable — EPS (TTM) ₹-0.09, 6 consecutive loss quarters. See Healthcare Services peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company has been reporting losses for 6 consecutive quarters. P/E ratio cannot be calculated for loss-making companies.
Consecutive Loss Quarters: 6
Current EPS: ₹-0.09
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | -0.05 | 0 | Loss |
| Mar 2025 | -0.09 | -1 | Loss |
| Jun 2025 | -0.06 | 0 | Loss |
| Dec 2025 | -0.05 | 0 | Loss |
| Sept 2024 | -0.01 | 0 | Loss |
| Mar 2024 | -0.04 | 0 | Loss |
| Jun 2024 | 0.03 | 0 | Profit |
| Dec 2024 | -0.01 | 0 | Loss |
Healthcare Services Peers with Valid P/E Ratios — TRABI Comparison
Healthcare Services sector average P/E 61.09, median 40.64 — TRABI excluded (negative EPS).
Sector Average PE
61.09
Sector Median PE
40.64
Lowest PE
6.55
Profitable Companies
48
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 6.55 | ₹99 | Low |
| Nidan Labs & Healthcare | NIDAN | 10.35 | ₹20 | Low |
| Deccan Health Care | DECCAN | 12.18 | ₹27 | Low |
| Shanmuga Hospital | SHANMUGA | 13.39 | ₹56 | Low |
| Abate AS Industries | ABATEAS | 17.43 | ₹182 | Moderate |
| 3B BlackBio DX | 3BBLACKBIO | 17.73 | ₹1,045 | Moderate |
| One Global Service Provi… | ONEGLOBAL | 17.94 | ₹1,165 | Moderate |
| Medinova Diagnostic Serv… | MEDINOV | 20.28 | ₹44 | Moderate |
| Clinitech Laboratory | CTLLAB | 20.81 | ₹8 | Moderate |
| Indraprastha Medical Cor… | INDRAMEDCO | 21.56 | ₹4,024 | Moderate |
Related Analysis
- For live price, revenue and the complete fundamental profile, see TRABI stock overview.
- Analyse TRABI FII DII holdings to track promoter, FII and institutional holdings.
- View TRABI 52-week chart for the annual high/low range and current price position.